about
Evaluation of poly(amidoamine) dendrimers as potential carriers of iminodiacetic derivatives using solubility studies and 2D-NOESY NMR spectroscopy.Adaptation of high-throughput screening in drug discovery-toxicological screening tests.Development of copper based drugs, radiopharmaceuticals and medical materials.Novel tetrahydroacridine and cyclopentaquinoline derivatives with fluorobenzoic acid moiety induce cell cycle arrest and apoptosis in lung cancer cells by activation of DNA damage signaling.New Biopolymer Nanoparticles Improve the Solubility of Lipophilic Megestrol Acetate.Taxodione and Extracts from Salvia austriaca Roots as Human Cholinesterase Inhibitors.Synthesis and biological evaluation of 1,3,4-thiadiazole analogues as novel AChE and BuChE inhibitors.New tacrine analogs as acetylcholinesterase inhibitors - theoretical study with chemometric analysis.New cyclopentaquinoline hybrids with multifunctional capacities for the treatment of Alzheimer's disease.Novel tetrahydroacridine derivatives with iodobenzoic acid moiety as multifunctional acetylcholinesterase inhibitors.Synthesis, physicochemical and biological studies of technetium-99m labeled tacrine derivative as a diagnostic tool for evaluation of cholinesterase level.Tetrahydroacridine derivatives with dichloronicotinic acid moiety as attractive, multipotent agents for Alzheimer's disease treatment.Metabolite Profiling of Eastern Teaberry (Gaultheria procumbens L.) Lipophilic Leaf Extracts with Hyaluronidase and Lipoxygenase Inhibitory Activity.Tetrahydroacridine derivatives with fluorobenzoic acid moiety as multifunctional agents for Alzheimer's disease treatment.Re-evaluation of the retention time prediction "polarity" model in the context of the development of a stationary phase variable.Synthesis, biological activity and HPLC validation of 1,2,3,4-tetrahydroacridine derivatives as acetylcholinesterase inhibitors.Synthesis and biological activity of new donepezil-hydrazinonicotinamide hybrids.Synthesis, biological evaluation and molecular modeling of new tetrahydroacridine derivatives as potential multifunctional agents for the treatment of Alzheimer's disease.Discovery of New Cyclopentaquinoline Analogues as Multifunctional Agents for the Treatment of Alzheimer's DiseaseSynthesis, biological activity and molecular modeling of 4-fluoro-N-[ω-(1,2,3,4-tetrahydroacridin-9-ylamino)-alkyl]-benzamide derivatives as cholinesterase inhibitorsNew tacrine-acridine hybrids as promising multifunctional drugs for potential treatment of Alzheimer's diseaseNovel tetrahydroacridine derivatives with iodobenzoic moieties induce G0/G1 cell cycle arrest and apoptosis in A549 non-small lung cancer and HT-29 colorectal cancer cellsBiological assessment of new tetrahydroacridine derivatives with fluorobenzoic moiety in vitro on A549 and HT-29 cell lines and in vivo on animal modelNew Tetrahydroacridine Hybrids with Dichlorobenzoic Acid Moiety Demonstrating Multifunctional Potential for the Treatment of Alzheimer's Disease
P50
Q30577158-6267398A-3462-4A92-9E58-E1B9B1528197Q35719340-31C073FE-6F4B-4E23-8FFB-5193393D217AQ36394415-96D44081-1BD3-4BD5-97E3-26C1FA9A5957Q38709882-AE214896-4589-44BA-8687-3A06F5801884Q38795341-F8C8CA61-F91B-4A46-9567-756FE8BFA415Q38815562-D3EAF113-AEA3-41CD-9B00-4503F614D807Q45736574-8A93C140-312A-460C-8D5D-0A1A309C2BF1Q45815071-FEACE5A9-428C-46F6-9058-B857B9B1A47AQ47324891-B24E892F-6CF0-4500-84A3-878DCF139BFFQ48297855-8915DE79-B4CC-4172-8925-260854C825E2Q48388555-5F5EA667-9DB5-4EAE-81D9-C9DD7BF10259Q49895777-06DCA6F1-26CD-4261-88BE-F8B498CBE99BQ50855906-602C5C0B-891B-46A9-BA73-C6EDB771EC74Q51003552-F6BCCFB6-D89B-4EB6-898D-13D535FD00C1Q51052199-5B687539-F936-4174-9A4D-43C16979F4ACQ53319073-892A80F9-678C-49A9-9A29-728CEA5DFBCAQ53337726-F9D1A15D-C309-43C1-9BE3-DAC048BCEEC8Q53366910-12C8C833-2B25-47D1-AADA-88FA261663D4Q64274407-CB4776CD-64E2-47C5-B0A7-DEC6608ECEE2Q85450051-47B46FFD-CFA2-417F-891C-B72247FA1280Q88995880-2B9A3173-4E09-4C70-8AB4-54AAFC37EF7DQ91945780-61BAA5A1-068C-4DCC-8F71-2FEE3F9B162AQ95656279-72723836-9586-4862-AF09-C1A55303B467Q95932151-8E5AC482-60A9-48B6-920B-B51CAECDC45C
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Paweł Szymański
@en
Paweł Szymański
@nl
type
label
Paweł Szymański
@en
Paweł Szymański
@nl
prefLabel
Paweł Szymański
@en
Paweł Szymański
@nl
P31
P496
0000-0003-3438-7509